• Indaptus Therapeutics Inc is trading 7.4% up at $4.19 in after-hours trading, rising from its regular-session close of $3.90.
  • Abbott Cooper PLLC announced an investigation on behalf of Indaptus Therapeutics, Inc. stockholders who held shares prior to December 22, 2025, concerning potential legal claims related to a private placement of preferred stock.
  • This legal investigation, announced on June 18, 2026, serves as a company-specific catalyst for the day's trading activity.